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ABSTRACT
Background It is important to understand the local
burden of non-communicable diseases including within-
country heterogeneity. The aim of this study was to
characterise hypertension and type-2 diabetes proﬁles
across different Peruvian geographical settings
emphasising the assessment of modiﬁable risk factors.
Methods Analysis of the CRONICAS Cohort Study
baseline assessment was conducted. Cardiometabolic
outcomes were blood pressure categories (hypertension,
prehypertension, normal) and glucose metabolism
disorder status (diabetes, prediabetes, normal).
Exposures were study setting and six modiﬁable factors
(smoking, alcohol drinking, leisure time and transport-
related physical activity levels, TV watching, fruit/
vegetables intake and obesity). Poisson regression
models were used to report prevalence ratios (PR).
Population attributable risks (PAR) were also estimated.
Results Data from 3238 participants, 48.3% male,
mean age 45.3 years, were analysed. Age-standardised
(WHO population) prevalence of prehypertension and
hypertension was 24% and 16%, whereas for
prediabetes and type-2 diabetes it was 18% and 6%,
respectively. Outcomes varied according to study setting
(p<0.001). In multivariable model, hypertension was
higher among daily smokers (PR 1.76), heavy alcohol
drinkers (PR 1.61) and the obese (PR 2.06); whereas
only obesity (PR 2.26) increased the prevalence of
diabetes. PAR showed that obesity was an important
determinant for hypertension (15.7%) and type-2
diabetes (23.9%).
Conclusions There is an evident heterogeneity in the
prevalence of and risk factors for hypertension and
diabetes within Peru. Prehypertension and prediabetes
are highly prevalent across settings. Our results
emphasise the need of understanding the epidemiology
of cardiometabolic conditions to appropriately implement
interventions to tackle the burden of non-communicable
diseases.
INTRODUCTION
Worldwide, non-communicable diseases (NCDs)
cause 36 million deaths annually,1 and are respon-
sible for 54% of disability-adjusted life years.2 In
one study, more than 60% of deaths from NCDs
were attributable to four preventable cardiometa-
bolic factors, with high-blood pressure having the
largest effect.1 Moreover, high-blood pressure con-
tinues to be the leading risk factor for mortality,
whereas mortality burden due to glucose metabol-
ism disorders, speciﬁcally type-2 diabetes, almost
doubled between the years 1980 to 2010.1
A modelling study reported that reducing the
prevalence of six risk factors, including smoking
and alcohol consumption, among others, would
contribute to reducing NCD mortality due to car-
diovascular disease and diabetes, with most of these
beneﬁts in low and middle-income countries
(LMICs).3 From a resource-constrained setting per-
spective, these ﬁndings point out that attention to
well-established modiﬁable risk factors need to be
addressed to reduce the negative burden of hyper-
tension and type-2 diabetes on mortality, as well as
their impact on organisation and costs of healthcare
delivery systems.4 5
Health research and development efforts for
NCDs in LMICs are limited, despite repeated calls
for action.6 Thus, for purposes of establishing pri-
ority, it is important to understand the local burden
of disease including within-country and between-
country heterogeneity of NCD proﬁles and their
risk factors. This would provide evidence to set
suitable interventions along with appropriate goals
and targets.2 On this information, strategies could
be deﬁned at the local and regional level. For
example, on the basis of global-scale policy scen-
arios, considering mortality beneﬁts and feasibility,
reductions in tobacco are recommended as a ‘best
buy’ initiative.3 Yet, within the Latin American
region, Peru shows much lower smoking rates,7
indicating that although smoking prevention is
needed in general, global ‘best buy’ policies require
local scrutiny and adaptation to maximise larger
preventative gains.
The aims of this study were to characterise the
proﬁle of two leading cardiometabolic conditions,
hypertension and type-2 diabetes, across distinct
Peruvian geographical settings. In addition,
emphasis was placed on the magnitude of the asso-
ciations between these cardiometabolic conditions
and modiﬁable risk factors in these settings, their
respective population attributable risks (PAR) and
the pattern of aggregation of common risk factors.
METHODS
Study design and setting
A cross-sectional, baseline assessment of the
CRONICAS cohort study8 was conducted between
the years 2010 and 2011 in four Peruvian settings
that differed by level of urbanisation, altitude and
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degree of household and environmental pollution: Pampas de
San Juan de Miraﬂores in Lima, a highly-urban setting; Puno, a
high altitude area located at 3830 m above sea level, contribut-
ing with urban and rural sites; and Tumbes, a semiurban coastal
location where rural farming and ﬁshing villages have become
intermixed with rapidly-growing urban areas. Detailed descrip-
tion of the four study sites is provided elsewhere.8
Participants
Individuals aged ≥35 years, full-time residents in the area, who
provided informed consent, were invited to participate in the
study. We identiﬁed a sex- and age-stratiﬁed random sample
(35–44, 45–54, 55–64 and ≥65 years) of potentially eligible
subjects. Single stage random sampling was conducted using the
most updated census available (year 2010) in each of the sites.
Only one participant per household was enrolled.
Study variables
Main outcomes were two: blood pressure status and glucose
metabolism disorder status. Blood pressure status was cate-
gorised based on hypertension and prehypertension deﬁnitions.
Hypertension was deﬁned as any of the following conditions:
systolic blood pressure (SBP) ≥140 mm Hg or diastolic blood
pressure (DBP) ≥90 mm Hg; or self-report of physician diagno-
sis and current use of antihypertensive drugs9; whereas prehy-
pertension was deﬁned as a systolic pressure from 120 to
139 mm Hg or a diastolic pressure from 80 to 89 mm Hg. On
the other hand, glucose metabolism disorder status was gener-
ated based on diabetes and prediabetes deﬁnitions. Diabetes was
deﬁned as any of the following conditions: fasting glucose
≥126 mg/dL; self-report of physician diagnosis and currently
receiving antihyperglycaemic medications; whereas prediabetes
was deﬁned as fasting plasma glucose values from 100 to
125 mg/dL.10
The main exposures were study site (Lima, urban Puno, rural
Puno and Tumbes, see settings above), and six well-established
modiﬁable factors associated with hypertension and diabetes:
daily smoking (≥1 cigarette/day, self-report), heavy alcohol
drinking (2 or more nights of alcohol intake in the past month
and having ever drunk 6 or more drinks at a time), leisure time
and transport-related physical activity based on the International
Physical Activity Questionnaire domains as recommended for
Latin American populations11), number of hours watching TV
(deﬁned as 2 or more hours watching TV per day during week-
days, self-report), fruit and vegetable intake (minimum con-
sumption recommended by World Health Organisation, ie, 5 or
more servings of fruits or vegetables per day12) and obesity
(using traditional body mass index (BMI) traditional cutoffs13).
Other variables of interest included in the analysis were self-
reported parental history of hypertension and/or diabetes, and
metabolic syndrome deﬁned by using the 2009 harmonised def-
inition that incorporates region-speciﬁc cut-off points.14
Sociodemographic variables were also included as potential con-
founders including sex, age (35–44, 45–54, 55–64 and 65+
years), education level (<7 years, 7–11 years and ≥12 years),
and socioeconomic status using a wealth index based on assets
and household facilities divided into tertiles.
Procedures
Participants responded to a detailed questionnaire. Fieldworkers
in rural areas were ﬂuent in Spanish, Aymara or Quechua and
they administered the survey to those with poor literacy.
Fieldworkers measured weight, height and blood pressure in
triplicate using standardised techniques.9 Fasting blood samples
were obtained and analysed in a single facility, and the quality
of assays was checked with regular external standards and
internal duplicate assays were monitored by BioRad (http://
www.biorad.com). Plasma glucose was measured using an
enzymatic colourimetric method (GOD-PAP, Modular P-E/
Roche-Cobas, Germany). Detailed information on evaluation
and measurement techniques is reported elsewhere.8
Statistical analysis
Statistical analyses were conducted in STATA V.13 (Stata Corp,
College Station, Texas, USA) in 2014. Characteristics of the popu-
lation were tabulated according to study site and comparisons were
performed using one-way analysis of variance or Kruskal-Wallis
test for numerical variables, and χ2 test for categorical variables.
Age-standardised prevalence of our outcomes of interest was calcu-
lated using WHO standard population distribution.15
Poisson regression with robust SEs16 was conducted to
compare blood pressure status (prehypertension vs normal
blood pressure, and hypertension vs normal blood pressure) and
glucose metabolism status (prediabetes vs normal glucose levels,
and diabetes vs normal glucose levels) according to study
setting. Four different models were built. Model 1 was the
crude model, only including the outcome and the exposure.
Model 2 also included age, sex, education level and socio-
economic status. Model 3 included the previous variables and
also parental history of hypertension/diabetes accordingly.
Finally, model 4, in addition, included obesity status. Poisson
regression was also used to determine the strength of association
between our six modiﬁable risk factors and our outcomes of
interest, controlling for age, sex, education level, socioeconomic
status and study site. Participants aware of their hypertension or
diabetes diagnosis were excluded from these models accordingly.
For all the regression models, prevalence ratios (PR) and 95%
conﬁdence intervals (95% CI) were calculated.
In addition, population attributable risk (PAR) was calculated
using the punaf command in STATA17, where estimations are
performed using the recommendation of Greenland and
Drescher for cross-sectional studies.18 Finally, calculations of the
cumulative effect of risk factors—adding common risk modiﬁ-
able factors—on our outcomes of interest were performed con-
trolling for potential confounders and results are presented
graphically using a Forest plot.
Ethics
All participants provided verbal informed consent due to high-
illiteracy rates, especially in rural areas. The study was approved
by the Institutional Review Boards at Universidad Peruana
Cayetano Heredia and AB PRISMA, in Lima, Peru, and at the
Bloomberg School of Public Health, Johns Hopkins University,
in Baltimore, USA.
RESULTS
Participant characteristics
Overall response rate after enrolment was 62.9% (4325/6872)
and, of these, 83.3% (3601/4325) completed all questionnaires.
Among those with completed questionnaires, 89.8% (3232/
3601) and 87.1% (3135/3601) had all clinical and blood labora-
tory evaluations completed, respectively (see online supplemen-
tary E-ﬁgure S1).
A total of 3238 participants, 48.3% male, mean age
45.3 years (IQR: 45.3–65.2), were included in the analysis. Of
them, 21.3% had ≥12 years of education and 90.3% had a
family income of <US$550 per month, indicating the predom-
inance of low socioeconomic status among participants.
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Detailed population characteristics as total and by study setting
are provided in table 1.
Prevalence of hypertension’s and diabetes’s awareness,
treatment and control and their association with study
setting
Age-standardised prevalence of prehypertension and hyperten-
sion was 23.7% (95% CI 22.3% to 25.1%) and 16.2% (95% CI
15.1% to 17.3%), respectively. Prevalence rates of these condi-
tions varied according to study setting (p<0.001), but there was
no uniform pattern: prehypertension was frequent in urban
Puno, but hypertension was more frequent in semiurban
Tumbes (table 1). Of the 641 cases of hypertension, 392
(61.3%) individuals were aware of their diagnosis, 318/392
(81.1%) reported to be on treatment and only 129/318 (40.6%)
had controlled blood pressure levels.
Similarly, age-standardised prevalence of prediabetes and dia-
betes was 18.1% (95% CI 16.9% to 19.5%) and 6.2% (95% CI
5.5% to 7%), respectively. Prediabetes and diabetes rates were
both higher in the semiurban setting (Tumbes) compared to the
others (p<0.001). Of the 217 cases of type-2 diabetes, 133
(61.3%) individuals were aware of their diagnosis, 95/133
(71.4%) reported to be on treatment and 60/95 (63.2%) had
controlled blood glucose levels.
Table 1 Participant characteristics: comparisons according to study site
Total Lima Urban Puno Rural Puno Tumbes
N=3238 n=1052 n=574 n=581 n=1031 p-value*
Sociodemographics—n (%)
Male 1565 (48.3%) 506 (48.1%) 277 (48.3%) 270 (46.5%) 512 (49.7%) 0.67
Age, years—median (IQR) 55.1 (45.3; 65.2) 54.8 (45.5; 64.7) 55.7 (45.3; 65.3) 55.9 (45.8; 65.9) 55.0 (44.9; 65.0) 0.34
Education level
<7 years 1492 (46.1%) 454 (43.2%) 91 (15.8%) 374 (64.1%) 573 (55.6%) <0.001
7–11 years 1056 (32.6%) 416 (39.6%) 156 (27.2%) 172 (29.5%) 312 (30.3%)
≥12 years 690 (21.3%) 181 (17.2%) 327 (57.0%) 37 (6.4%) 145 (14.1%)
Socioeconomic Status (tertiles)
Lowest 1021 (31.5%) 127 (12.1%) 135 (23.5%) 419 (72.1%) 340 (33.0%) <0.001
Middle 1107 (34.2%) 387 (36.8%) 155 (27.0%) 147 (25.3%) 418 (40.5%)
Highest 1110 (34.3%) 538 (51.1%) 284 (49.5%) 15 (2.6%) 273 (26.5%)
Lifestyles—n (%)
Daily smoking 103 (3.2%) 34 (3.2%) 12 (2.1%) 1 (0.2%) 56 (5.4%) <0.001
Heavy alcohol drinking 172 (5.3%) 58 (5.5%) 37 (6.5%) 17 (2.9%) 60 (5.8%) 0.03
Leisure time and transport-related physical activity
Lowest 1031 (31.9%) 201 (19.1%) 122 (21.3%) 149 (25.6%) 559 (54.2%) <0.001
Moderate 1784 (55.1%) 637 (60.6%) 372 (65.0%) 360 (61.9%) 415 (40.3%)
Highest 421 (13.0%) 213 (20.3%) 78 (13.6%) 73 (12.5%) 57 (5.5%)
Hours watching TV (2+ hours per day) 1382 (42.7%) 509 (48.4%) 265 (46.2%) 83 (14.3%) 525 (50.9%) <0.001
Fruits and vegetables intake (5+ servings per day) 132 (4.1%) 70 (6.7%) 38 (6.6%) 11 (1.9%) 13 (1.3%) <0.001
Parental history—n (%)
Hypertension among at least one of the parents 683 (21.1%) 192 (18.3%) 120 (20.9%) 25 (4.3%) 346 (33.6%) <0.001
Diabetes among at least one of the parents 238 (7.4%) 74 (7.0%) 32 (5.6%) 3 (0.5%) 129 (12.5%) <0.001
Anthropometric measurements—n (%)
Body mass index
Normal weight (BMI <25 kg/m2) 953 (29.5%) 243 (23.2%) 135 (24.0%) 317 (54.5%) 255 (24.7%) <0.001
Overweight (BMI ≥25–29.9 kg/m2) 1409 (43.6%) 471 (45.0%) 278 (49.4%) 206 (35.4%) 450 (43.7%)
Obesity (BMI ≥30 kg/m2) 869 (26.9%) 332 (31.7%) 150 (26.6%) 59 (10.1%) 326 (31.6%)
Clinical Profile
SBP (mm Hg)—mean (SD) 117.6 (19.1) 117.4 (18.8) 112.2 (17.5) 116.5 (17.3) 121.5 (20.3) <0.001
DBP (mm Hg)—mean (SD) 73.4 (11.1) 72.8 (11.2) 71.8 (10.1) 75.2 (10.1) 74.0 (11.8) <0.001
Fasting glucose (mg/dL)—mean (SD) 98.2 (33.9) 97.7 (33.2) 96.6 (32.4) 90.2 (21.3) 103.6 (39.4) <0.001
A1c (%)—mean (SD) 6.0 (1.2) 5.9 (1.1) 6.0 (1.1) 5.9 (0.8) 6.2 (1.4) <0.001
Cardiometabolic condition—n (%)
Blood pressure
Normal 1799 (55.4%) 589 (56.0%) 394 (68.6%) 327 (56.3%) 481 (46.7%) <0.001
Prehypertension 809 (24.9%) 251 (23.9%) 101 (17.6%) 182 (31.3%) 273 (26.5%)
Hypertension 641 (19.7%) 212 (20.1%) 79 (13.8%) 72 (12.4%) 277 (26.9%)
Glucose metabolism disorder
Normal 2313 (74.2%) 767 (74.4%) 395 (76.7%) 473 (87.5%) 678 (65.7%) <0.001
Prediabetes 588 (18.8%) 207 (20.1%) 83 (16.1%) 51 (9.4%) 247 (24.0%)
Diabetes 217 (7.0%) 57 (5.5%) 37 (7.2%) 17 (3.1%) 106 (10.3%)
Metabolic syndrome 1465 (47.0%) 505 (49.0%) 246 (47.9%) 150 (27.7%) 564 (54.8%) <0.001
*p-values were calculated comparing study sites using one-way analysis of variance or Kruskal–Wallis test for numerical variables, and χ2 test for categorical variables.
A1c, glycated haemoglobin; BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure. Results may not add up due to missing values.
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Association between cardiometabolic outcomes and
study site
Results of the multivariable models did not show a clear pattern
of association between study setting and the outcomes of inter-
est: Tumbes, the semiurban setting, had higher prevalence of
prehypertension, hypertension, prediabetes and diabetes, when
compared to Lima. In addition, urban Puno had lower prehy-
pertension and hypertension rates when compared to Lima,
whereas rural Puno had greater prevalence of prehypertension
but not of hypertension and lower prevalence of prediabetes but
not diabetes (table 2).
Prevalence of main modiﬁable factors
Overall prevalence of daily smoking, intake of 5+ fruits/vegeta-
bles portions and heavy alcohol drinking were below 5%.
Almost one-third of the study population had low levels of
leisure time and transport-related physical activity, whereas
42.7% reported watching TV two or more hours per day.
Finally, the overall prevalence of obesity was 26.9%. As shown
in table 1, these factors were statistically different when com-
pared by study site.
When evaluating the pattern of aggregation of risk factors,
only 1.2% (38/3213) had no risk factors studied, 29.1% (935/
3213) had one risk factor, 39.4% (1267/3213) had two risk
factors, 23.6% (758/3213) had three risk factors and 6.7%
(215/3213) had four or more risk factors.
Association between cardiometabolic outcomes and
modiﬁable factors
Of the six main modiﬁable factors studied, and after adjusting
for potential confounders, both heavy alcohol drinking and
obesity were positively associated with prehypertension. In add-
ition, there was evidence that daily smoking, heavy alcohol
drinking and obesity were associated with higher prevalence of
hypertension. On the other hand, only obesity was positively
associated with prediabetes and diabetes (table 3).
When the cumulative effect of risk factors was evaluated,
there was a clear increasing trend in the prevalence of prehyper-
tension and hypertension with increased number of risk factors.
A similar pattern was observed for prediabetes and diabetes
(ﬁgure 1).
Population attributable risks of the main modiﬁable factors
In the case of hypertension, PAR of daily smoking and heavy
alcohol drinking were low, 3% and 2.7%, respectively; whereas
PAR of low fruits and vegetable intake, and obesity, were high,
57.9% and 15.7%, respectively. In the case of diabetes, PAR of
smoking was low (0.8%), whereas PAR of low levels of leisure
time and transport-related physical activity (12%), daily watch-
ing TV (12.5%) and obesity (23.9%), were high.
Additionally, in the four study settings, obesity was consist-
ently the leading risk factor for hypertension, ranging from
9.5% in rural Puno to 24.1% in urban Puno; and for diabetes,
from 2.4% in rural Puno to 61.2% in Lima. See details in
online supplementary (E-table S1).
DISCUSSION
Main ﬁndings
Our ﬁndings signal the heterogeneity and risk factors of hyperten-
sion and type-2 diabetes prevalence within resource-constrained
settings in a Latin American country. Moreover, this heterogeneity
was also present when using population-attributable risk calcula-
tions. Our results, taken with the mixed geographical character-
istics of Peru, which include high altitude and sea-level settings
together with rural, semiurban and highly-urbanised areas, suggest
the need to appropriately understand the epidemiology of
Table 2 Hypertension and diabetes according to study setting: bivariable and multivariable models using multinomial logistic regression
Model 1 Model 2 Model 3 Model 4
PR (95% CI) PR (95% CI) PR (95% CI) PR (95% CI)
Prehypertension (vs normal)
Lima 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference)
Urban Puno 0.68 (0.56 to 0.84) 0.64 (0.52 to 0.79) 0.64 (0.52 to 0.79) 0.64 (0.52 to 0.79)
Rural Puno 1.20 (1.03 to 1.40) 1.20 (1.01 to 1.43) 1.22 (1.02 to 1.45) 1.28 (1.07 to 1.53)
Tumbes 1.21 (1.05 to 1.39) 1.24 (1.07 to 1.42) 1.19 (1.03 to 1.38) 1.18 (1.02 to 1.36)
Hypertension (vs normal)
Lima 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference)
Urban Puno 0.63 (0.50 to 0.80) 0.59 (0.47 to 0.75) 0.61 (0.48 to 0.77) 0.57 (0.44 to 0.73)
Rural Puno 0.68 (0.54 to 0.86) 0.68 (0.53 to 0.88) 0.73 (0.56 to 0.94) 0.81 (0.62 to 1.04)
Tumbes 1.38 (1.19 to 1.60) 1.36 (1.18 to 1.57) 1.24 (1.08 to 1.43) 1.30 (1.12 to 1.50)
Prediabetes (vs normal)
Lima 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference)
Urban Puno 0.81 (0.65 to 1.02) 0.76 (0.60 to 0.98) 0.77 (0.61 to 0.99) 0.80 (0.63 to 1.01)
Rural Puno 0.46 (0.34 to 0.61) 0.58 (0.42 to 0.79) 0.58 (0.42 to 0.80) 0.66 (0.49 to 0.91)
Tumbes 1.26 (1.07 to 1.48) 1.39 (1.18 to 1.64) 1.38 (1.16 to 1.63) 1.36 (1.16 to 1.61)
Type 2 diabetes (vs normal)
Lima 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference)
Urban Puno 1.25 (0.85 to 1.84) 1.34 (0.88 to 2.05) 1.42 (0.94 to 2.14) 1.43 (0.95 to 2.15)
Rural Puno 0.48 (0.29 to 0.82) 0.61 (0.35 to 1.06) 0.64 (0.37 to 1.12) 0.75 (0.42 to 1.31)
Tumbes 1.89 (1.40 to 2.56) 2.04 (1.49 to 2.80) 1.89 (1.37 to 2.57) 1.93 (1.40 to 2.66)
Estimates in bold are significant (p<0.05).
Model 1: crude model.
Model 2: adjusted by age, sex, education level and socioeconomic status.
Model 3: as model 2 plus adjustment by parental history of hypertension/diabetes.
Model 4: as model 3 plus adjustment by obesity status.
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cardiometabolic risk factors between and within countries. These
ﬁndings contribute towards a better understanding of the diversity
of disease burden, which is needed to establish appropriate inter-
ventions to tackle NCDs.
Settings and prevalence of hypertension and type-2 diabetes
Prevalence of our main cardiometabolic outcomes was very het-
erogeneous and not uniformly distributed as expected. For
example, given the degree of socioeconomic development and
urbanisation of Lima, a priori it would be expected that all
other settings should have lower rates of hypertension and
diabetes than Peru’s capital. Yet our results showed that, after
controlling for potential confounders, individuals residing in
Tumbes had 18% more prehypertension and 30% more hyper-
tension. On the other hand, rural Puno had 28% more prehy-
pertension rates but 19% less hypertension, though the latter
was not signiﬁcant. In the case of glucose metabolism status,
Tumbes had greater prevalence of prediabetes (36% more) and
type-2 diabetes (93% more) than Lima.
Potential explanations for these ﬁndings can be related to dif-
ferential progression and staging within the epidemiological and
nutrition transition, even within the same country. Peru is
Table 3 Modifiable risk factors associated with hypertension and diabetes: overall crude and adjusted estimates using multinomial logistic
regression
Crude model Adjusted model* Crude model Adjusted model*
PR (95% CI) PR (95% CI) PR (95% CI) PR (95% CI)
Prehypertension Prediabetes
Daily smoking (yes vs no) 1.09 (0.77 to 1.53) 0.95 (0.69 to 1.31) 0.97 (0.64 to 1.49) 0.82 (0.54 to 1.24)
Heavy alcohol drinking (yes vs no) 1.44 (1.17 to 1.78) 1.30 (1.06 to 1.60) 1.10 (0.81 to 1.50) 1.14 (0.83 to 1.55)
Leisure and transport-related PA (moderate/high vs low) 0.99 (0.87 to 1.14) 0.97 (0.85 to 1.12) 0.88 (0.75 to 1.02) 1.00 (0.84 to 1.19)
Daily hours watching TV (2+ vs <2 h) 1.01 (0.90 to 1.15) 1.07 (0.94 to 1.21) 1.26 (1.09 to 1.46) 1.09 (0.94 to 1.27)
Fruits and vegetables intake (5+ vs <5 servings/day) 0.72 (0.49 to 1.06) 0.85 (0.58 to 1.25) 0.74 (0.47 to 1.17) 0.75 (0.48 to 1.17)
Obesity (BMI ≥30 kg/m2) 1.11 (0.96 to 1.27) 1.33 (1.16 to 1.53) 2.03 (1.76 to 2.35) 1.84 (1.59 to 2.13)
Hypertension Diabetes
Daily smoking (yes vs no) 2.13 (1.39 to 3.26) 1.76 (1.23 to 2.53) 1.44 (0.54 to 3.84) 1.19 (0.46 to 3.07)
Heavy alcohol drinking (yes vs no) 1.55 (1.01 to 2.39) 1.61 (1.08 to 2.40) 0.66 (0.21 to 2.06) 0.74 (0.24 to 2.32)
Physical activity (moderate/high vs low) 0.87 (0.68 to 1.11) 1.07 (0.83 to 1.37) 0.49 (0.32 to 0.75) 0.75 (0.47 to 1.21)
Daily hours watching TV (2+ vs <2 h) 0.86 (0.67 to 1.09) 1.03 (0.81 to 1.31) 1.45 (0.95 to 2.20) 1.33 (0.88 to 2.01)
Fruits and vegetables intake (5+ vs <5 servings /day) 0.31 (0.10 to 0.93) 0.41 (0.14 to 1.23) 1.18 (0.44 to 3.15) 1.54 (0.57 to 4.15)
Obesity (BMI ≥30 kg/m2) 1.43 (1.12 to 1.84) 2.06 (1.60 to 2.65) 2.58 (1.70 to 3.94) 2.26 (1.48 to 3.45)
Estimates in bold are significant (p<0.05). Participants aware of hypertension/diabetes diagnosis were excluded from the analysis accordingly.
*Adjusted by sex, age, education level, socioeconomic status and study site, using robust SEs.
BMI, body mass index; PA, physical activity; PR, prevalence ratio.
Figure 1 Forest plot of the association between outcomes of interest and number of modiﬁable risk factors. Participants aware of hypertension or
diabetes diagnosis were excluded from the analysis accordingly. *Prevalence ratios (PR) were adjusted by sex, age, education level and
socioeconomic status. Study site was included in the model as cluster with robust SEs.
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currently considered an upper-middle-income country, and
more than 40% of total years of life lost due to premature mor-
tality is because of NCDs.19 Peru’s diverse geography along
with unequal societal development accounts for different stages
of the epidemiological and nutrition transition in different
populations.20–23 Similar settings, especially in the Latin
American region, might face similar challenges. Moreover,
although a clear relationship between urbanicity and common
modiﬁable risk factors for chronic disease has been reported,24
including mortality for cardiovascular events25; to a certain
extent, the differences observed between urban and rural set-
tings in our study may not be completely explained by urbanisa-
tion. As a result, the need of understanding the burden of
NCDs proﬁles, including within-country and between-country
heterogeneity, should be encouraged.
Modiﬁable risk factors associated with hypertension/diabetes
Prevalence of daily smoking and heavy alcohol drinking was
low, while almost a third of the study population had low levels
of leisure time and transport-related physical activity and
obesity. The consumption of fruits and vegetables according to
the WHO recommendation was low. Similar trends have been
reported in other developing countries. In rural settings in
Nigeria, abdominal obesity, physical inactivity, smoking and
alcohol consumption rates were 38.5%, 29.8%, 2.9% and 1%,
respectively.26
Regarding hypertension, our results are similar to those previ-
ously reported in developing countries. For example, in rural
Zambia, BMI was independently associated with hypertension,
and so was smoking.27 In Vietnam, there was higher prevalence
of hypertension in overweight men and alcohol drinkers.28 In
Nepal, patients with hypertension are less physically active
when compared to non-hypertensive people.29 Diet also
matters; in China, people with a western diet have a higher like-
lihood of hypertension.30
Our results regarding diabetes and modiﬁable risk factors are
similar to previous reports in developing countries. A study in
Lebanon reported that being obese was associated with higher
odds of diabetes, though vigorous physical activity had the
opposite impact31; in addition, there was almost half the
number of people with diabetes in comparison to healthy
people, who were physically active.32 In Nepal, people with dia-
betes, in comparison to their healthy peers, are less physically
active.29 Abdominal obesity is also associated with higher odds
of elevated plasma glucose, as seen in females in rural
Uganda.33
In addition, the cluster of different risk factors within a given
subject is also a concern. In an urban setting in Sri Lanka, 23%
had two or more risk factors, among which were physical
inactivity, central obesity, family history of type-2 diabetes and
BMI.34 In Malaysia, a national survey revealed that 14% of the
population had three or more risk factors: hyperglycaemia,
hypertension, hypercholesterolaemia and central obesity.35 Our
ﬁndings, based on modiﬁable risk factors, showed that more
than two-thirds of participants had two or more of our selected
modiﬁable risk factors.
Despite similarities between countries, Peru has a unique
proﬁle regarding low levels of tobacco consumption: less than
5% of the participants reported daily smoking, and this value
was even lower in the rural setting. Although the prevalence of
smoking is low in our context, deleterious effects are well
known. Most studies of NCDs have been constrained to one
rural versus one urban study site, thus limiting the assessment of
potential within-country heterogeneities. Moreover, reports of
NCDs in high-altitude rural settings are very scarce. Under these
circumstances, our study expands on better characterisation of
the burden of disease in resource-constrained settings to appro-
priately implement strategies.
Population attributable risks
Not all well-known modiﬁable risk factors were associated with
our outcomes of interest. Despite the cross-sectional nature of
our study, our results suggest that obesity might play an import-
ant role in developing hypertension and diabetes. Obesity,
assessed by BMI, was the leading factor associated with both
hypertension and diabetes, and was the same for prehyperten-
sion and prediabetes. Nevertheless, interpretation needs to be
cautious, as PAR will represent the proportion of prevalent
disease cases that can be attributed to exposure.36 Thus,
although our results are compatible with the nutritional transi-
tion that low-income and middle-income countries are going
through, further longitudinal studies are needed to corroborate
our ﬁndings.
Strengths and limitations
Major strengths of this study include its population-based
design, the diverse geographical settings involved and the
random selection of participants as well as the objective meas-
urement of outcomes using standardised techniques. However,
this study also has limitations. First, this study was not nation-
ally representative and, thus, the inclusion of other different set-
tings, for example, Amazonian rainforest settings, was not
possible. Second, the cross-sectional nature of the study prevents
establishing a causal link. However, selected variables have been
reported as risk factors for developing cardiometabolic out-
comes. Third, temporality and reverse causality can be an issue
despite excluding those aware of hypertension or diabetes from
PR and PAR calculations. Fourth, misclassiﬁcation could arise,
especially in the exposure variables, as many of them (ie,
smoking, alcohol use, fruits and vegetables intake) were self-
reported. Nevertheless, we used standardised questionnaires,
including WHO STEPs, to be consistent in measure. Finally,
there are inherent assumptions that need to be accounted for in
PAR calculations, such as the use of data from individuals with
prevalent disease instead of incident cases, and unmeasured con-
founding, among others.36 37
CONCLUSIONS
Within Peru, an evident heterogeneity in the proﬁle of hyperten-
sion and diabetes is described. Notoriously, in addition to the
diversity of patterns, the prevalence of prehypertension and pre-
diabetes was also high across sites, signalling major future chal-
lenges for disease prevention. Our results emphasise the need
for a better understanding of the epidemiology of cardiometa-
bolic conditions to appropriately implement interventions to
tackle the burden of NCDs.
What is already known on the subject
▸ Reducing the prevalence of risk factors such as smoking and
alcohol consumption, among others, would contribute to
reducing mortality due to cardiovascular disease and
diabetes.
▸ Globally, high-blood pressure is a major leading risk factor
for mortality, and mortality related to glucose metabolism
disorders has increased rapidly.
6 Bernabé-Ortiz A, et al. J Epidemiol Community Health 2015;0:1–7. doi:10.1136/jech-2015-205988
Research report
What this study adds
▸ There is evident heterogeneity in the proﬁle of hypertension
and diabetes in different settings in Peru.
▸ Aggregation of national estimates of disease burden can
blur the proﬁle of cardiometabolic markers, including
hypertension and diabetes, which can vary widely within a
country. Understanding of these variations is needed to
establish appropriate interventions.
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